Vendome Acquisition Corporation I Reports Quarterly Financials and IPO Success

Vendome Acquisition Corporation I has released its quarterly financial report for the period ending June 30, 2025, revealing a total asset value of $957,884, which includes $73,592 in cash and $884,292 in deferred offering costs. The company reported no revenue or operating expenses during this period, resulting in a net loss of $0. The weighted average number of ordinary shares outstanding was 5,000,000, with a basic and diluted net loss per share of $(0.00). This marks a continuation of the company's early-stage status, as it has not yet commenced operations or generated revenue since its inception on January 28, 2025.

In terms of financial changes, Vendome Acquisition Corporation I has made significant strides since its inception. The company successfully completed its Initial Public Offering (IPO) on July 3, 2025, selling 20,000,000 units at $10.00 each, generating gross proceeds of $200 million. Additionally, it raised $2.648 million through the private sale of 2,648,000 warrants to its sponsor and underwriters. The total transaction costs associated with the IPO amounted to $2,105,782, which included a $1 million underwriting fee.

Operationally, the company has not yet engaged in any business combinations or acquisitions, as it is still in the process of identifying potential target businesses. As of June 30, 2025, Vendome had a working capital deficit of $859,292, which it plans to address through the proceeds from its IPO and private placement. The company has also established a trust account where the IPO proceeds will be held, primarily to fund future business combinations. The management has indicated that they will utilize the funds for due diligence, travel, and other expenses related to identifying and evaluating potential acquisition targets.

Looking ahead, Vendome Acquisition Corporation I aims to leverage the capital raised to pursue a business combination with a target company, focusing on high-potential businesses primarily based in the United States. The company has expressed confidence in its ability to meet its operational needs through the funds raised, although it acknowledges the inherent risks associated with early-stage companies and the uncertainties in completing a business combination. The management's outlook remains cautiously optimistic, with plans to utilize the funds effectively to identify and negotiate potential acquisitions in the coming months.